Inhibition of hepatic cells pyroptosis attenuates CLP-induced acute liver injury

American Journal of Translational Research

Volumn 8, Issue 12, 2016, Pages 5685-5695

  Chen, Yuan Li ^a,b   Xu, Guo ^c   Liang, Xiao ^d   Wei, Juan ^a,e   Luo, Jing ^a,b   Chen, Guan Nan ^a   Yan, Xiao Di ^g   Wen, Xue Ping ^h   Zhong, Ming ^f   Lv, Xin ^a,b  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b XUZHOU MEDICAL UNIVERSITY   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

^d WUXI NO 2 PEOPLE S HOSPITAL   (China)

^e SOOCHOW UNIVERSITY   (China)

^f FUDAN UNIVERSITY   (China)

^g SECOND MILITARY MEDICAL UNIVERSITY   (China)

^h Ningxiang People s Hospital of Hunan Province   (China)

Author keywords

Acute liver injury; Pyroptosis; Sepsis

Indexed keywords

AC YVAD CMK; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CASPASE INHIBITOR; CRYOPYRIN; GLIBENCLAMIDE; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CECAL LIGATION AND PUNCTURE-INDUCED SEPSIS; CELL ISOLATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HISTOPATHOLOGY; LIVER CELL; LIVER INJURY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PYROPTOSIS; SEPSIS; WESTERN BLOTTING;

EID: 85007579938     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Andries O, De Filette M, De Smedt SC, Demeester J, Van Poucke M, Peelman L and Sanders NN. Innate immune response and programmed cell death following carrier-mediated delivery of unmodified mRNA to respiratory cells. J Control Release 2013; 167: 157-166.
2. Galley HF. Oxidative stress and mitochondrial dysfunction in sepsis. Br J Anaesth 2011; 107: 57-64.
3. Stearns-Kurosawa DJ, Osuchowski MF, Valentine C, Kurosawa S and Remick DG. The pathogenesis of sepsis. Annu Rev Pathol 2011; 6: 19-48.
4. van der Poll T and Opal SM. Host-pathogen interactions in sepsis. Lancet Infect Dis 2008; 8: 32-43.
5. Hotchkiss RS and Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348: 138-150.
6. Yan GT, Xue H, Lin J, Hao XH, Zhang K and Wang LH. Changes of hepatic function in sepsis mice and protective effects of Leptin on it. Acad J Sec Mil Med Univ 2006; 27: 268-271.
7. Ely EW, Kleinpell RM and Goyette RE. Advances in the understanding of clinical manifestations and therapy of severe sepsis: an update for critical care nurses. Am J Crit Care 2003; 12: 120-133; quiz 134-125.
8. Xu Z, Huang Y, Mao P, Zhang J and Li Y. Sepsis and ARDS: the dark side of histones. Mediators Inflamm 2015; 2015: 205054.
9. Tukov FF, Luyendyk JP, Ganey PE and Roth RA. The role of tumor necrosis factor alpha in lipopolysaccharide/ranitidine-induced inflammatory liver injury. Toxicol Sci 2007; 100: 267-280.
10. Zhang HB, Luo HC, Xin XJ and Zeng AZ. Up-regulated reg proteins induced by Interleukin-22 treatment ameliorate acute liver injury in rat model. Int J Clin Exp Med 2015; 8: 1253-1258.
11. Kurts C, Panzer U, Anders HJ and Rees AJ. The immune system and kidney disease: basic concepts and clinical implications. Nat Rev Immunol 2013; 13: 738-753.
12. Pires-Neto RC, Morales MM, Lancas T, Inforsato N, Duarte MI, Amato MB, de Carvalho CR, da Silva LF, Mauad T and Dolhnikoff M. Ex-pression of acute-phase cytokines, surfactant proteins, and epithelial apoptosis in small airways of human acute respiratory distress syndrome. J Crit Care 2013; 28: 111.e119-111.e115.
13. Jaeschke H. Inflammation in response to hepatocellular apoptosis. Hepatology 2002; 35: 964-966.
14. Chida Y, Sudo N, Takaki A and Kubo C. The hepatic sympathetic nerve plays a critical role in preventing Fas induced liver injury in mice. Gut 2005; 54: 994-1002.
15. Miao EA, Leaf IA, Treuting PM, Mao DP, Dors M, Sarkar A, Warren SE, Wewers MD and Aderem A. Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nat Immunol 2010; 11: 1136-1142.
16. Bauernfeind F and Hornung V. Of inflammasomes and pathogens-sensing of microbes by the inflammasome. EMBO Mol Med 2013; 5: 814-826.
17. Shi J, Zhao Y, Wang Y, Gao W, Ding J, Li P, Hu L and Shao F. Inflammatory caspases are in-nate immune receptors for intracellular LPS. Nature 2014; 514: 187-192.
18. Cervantes J, Nagata T, Uchijima M, Shibata K and Koide Y. Intracytosolic Listeria monocytogenes induces cell death through caspase-1 activation in murine macrophages. Cell Microbiol 2008; 10: 41-52.
19. Suzuki H, Sozen T, Hasegawa Y, Chen W and Zhang JH. Caspase-1 inhibitor prevents neurogenic pulmonary edema after subarachnoid hemorrhage in mice. Stroke 2009; 40: 3872-3875.
20. Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, Abela GS, Franchi L, Nunez G, Schnurr M, Espevik T, Lien E, Fitzgerald KA, Rock KL, Moore KJ, Wright SD, Hornung V and Latz E. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010; 464: 1357-1361.
21. Rittirsch D, Huber-Lang MS, Flierl MA and Ward PA. Immunodesign of experimental sepsis by cecal ligation and puncture. Nat Protoc 2009; 4: 31-36.
22. West MA, Keller GA, Cerra FB and Simmons RL. Killed Escherichia coli stimulates macrophage-mediated alterations in hepatocellular function during in vitro coculture: a mechanism of altered liver function in sepsis. Infect Immun 1985; 49: 563-570.
23. Christaki E, Anyfanti P and Opal SM. Immunomodulatory therapy for sepsis: an update. Expert Rev Anti Infect Ther 2011; 9: 1013-1033.
24. Giamarellos-Bourboulis EJ and Raftogiannis M. The immune response to severe bacterial infections: consequences for therapy. Expert Rev Anti Infect Ther 2012; 10: 369-380.
25. Wang P and Chaudry IH. Mechanism of hepatocellular dysfunction during hyperdynamic sepsis. Am J Physiol 1996; 270: R927-938.
26. Menzel CL, Sun Q, Loughran PA, Pape HC, Billiar TR and Scott MJ. Caspase-1 is hepatoprotective during trauma and hemorrhagic shock by reducing liver injury and inflammation. Mol Med 2011; 17: 1031-1038.
27. Labbe K and Saleh M. Cell death in the host response to infection. Cell Death Differ 2008; 15: 1339-1349.
28. Fink SL and Cookson BT. Caspase-1-dependent pore formation during pyroptosis leads to osmotic lysis of infected host macrophages. Cell Microbiol 2006; 8: 1812-1825.
29. Zhao D, Wu Y, Zhuang J, Xu C and Zhang F. Activation of NLRP1 and NLRP3 inflammasomes contributed to cyclic stretch-induced pyroptosis and release of IL-1beta in human periodontal ligament cells. Oncotarget 2016; [Epub ahead of print].
30. Cao Y, Fei D, Chen M, Sun M, Xu J, Kang K, Jiang L and Zhao M. Role of the nucleotide-binding domain-like receptor protein 3 inflammasome in acute kidney injury. FEBS J 2015; 282: 3799-3807.
31. Wu DD, Pan PH, Liu B, Su XL, Zhang LM, Tan HY, Cao Z, Zhou ZR, Li HT, Li HS, Huang L and Li YY. Inhibition of alveolar macrophage py-roptosis reduces lipopolysaccharide-induced acute lung injury in mice. Chin Med J (Engl) 2015; 128: 2638-2645.
32. Rouquet N, Pages JC, Molina T, Briand P and Joulin V. ICE inhibitor YVADcmk is a potent therapeutic agent against in vivo liver apoptosis. Curr Biol 1996; 6: 1192-1195.
33. Cookson BT and Brennan MA. Pro-inflammatory programmed cell death. Trends Microbiol 2001; 9: 113-114.